Response Genetics, Inc (RGDXQ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2015 | 3.94 Million USD | -41.24% |
| 2014 | 6.7 Million USD | -28.21% |
| 2013 | 9.34 Million USD | 12.31% |
| 2012 | 8.32 Million USD | -23.73% |
| 2011 | 10.9 Million USD | 0.86% |
| 2010 | 10.81 Million USD | 223.28% |
| 2009 | 3.34 Million USD | -5.23% |
| 2008 | 3.53 Million USD | -5.71% |
| 2007 | 3.74 Million USD | 5.14% |
| 2006 | 3.56 Million USD | -31.11% |
| 2005 | 5.16 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2015 FY | 3.94 Million USD | -41.24% |
| 2015 Q1 | 1.47 Million USD | -9.7% |
| 2014 Q2 | 1.69 Million USD | 16.4% |
| 2014 Q3 | 1.92 Million USD | 13.38% |
| 2014 Q4 | 1.63 Million USD | -14.97% |
| 2014 Q1 | 1.45 Million USD | -36.6% |
| 2014 FY | 6.7 Million USD | -28.21% |
| 2013 Q1 | 3.09 Million USD | 3.14% |
| 2013 Q4 | 2.29 Million USD | 69.91% |
| 2013 Q2 | 2.6 Million USD | -15.68% |
| 2013 Q3 | 1.35 Million USD | -48.11% |
| 2013 FY | 9.34 Million USD | 12.31% |
| 2012 FY | 8.32 Million USD | -23.73% |
| 2012 Q4 | 2.99 Million USD | 13.73% |
| 2012 Q3 | 2.63 Million USD | 87.0% |
| 2012 Q2 | 1.4 Million USD | 10.0% |
| 2012 Q1 | 1.28 Million USD | 5.13% |
| 2011 Q2 | 3.9 Million USD | 20.92% |
| 2011 Q4 | 1.21 Million USD | -52.46% |
| 2011 FY | 10.9 Million USD | 0.86% |
| 2011 Q1 | 3.22 Million USD | -2.07% |
| 2011 Q3 | 2.56 Million USD | -34.32% |
| 2010 Q4 | 3.29 Million USD | 16.19% |
| 2010 Q2 | 3.12 Million USD | 99.76% |
| 2010 Q1 | 1.56 Million USD | 20.5% |
| 2010 FY | 10.81 Million USD | 223.28% |
| 2010 Q3 | 2.83 Million USD | -9.17% |
| 2009 FY | 3.34 Million USD | -5.23% |
| 2009 Q1 | 345.02 Thousand USD | -50.46% |
| 2009 Q4 | 1.29 Million USD | 19.68% |
| 2009 Q2 | 619.69 Thousand USD | 79.61% |
| 2009 Q3 | 1.08 Million USD | 74.91% |
| 2008 Q3 | 931.64 Thousand USD | 1.45% |
| 2008 Q1 | 983.97 Thousand USD | -24.62% |
| 2008 FY | 3.53 Million USD | -5.71% |
| 2008 Q4 | 696.48 Thousand USD | -25.24% |
| 2008 Q2 | 918.3 Thousand USD | -6.67% |
| 2007 FY | 3.74 Million USD | 5.14% |
| 2007 Q4 | 1.3 Million USD | -1.83% |
| 2007 Q3 | 1.32 Million USD | 325.72% |
| 2007 Q2 | 312.3 Thousand USD | -60.81% |
| 2007 Q1 | 796.92 Thousand USD | -41.61% |
| 2006 Q4 | 1.36 Million USD | 55.98% |
| 2006 FY | 3.56 Million USD | -31.11% |
| 2006 Q3 | 875.07 Thousand USD | -31.63% |
| 2006 Q1 | 1.26 Million USD | 0.0% |
| 2006 Q2 | 1.27 Million USD | 0.87% |
| 2005 FY | 5.16 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 2142.487% |
| Arrayit Corporation | 2.57 Million USD | -53.084% |
| Atlantic International Corp. | -154.23 Thousand USD | 2655.857% |
| Biocept, Inc. | -2.58 Million USD | 252.672% |
| Bioqual, Inc. | 7.42 Million USD | 46.939% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -1328.261% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.942% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -119.722% |
| iMD Companies, Inc. | -23.63 Thousand USD | 16777.243% |
| IDenta Corp. | 662.97 Thousand USD | -494.593% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 82.893% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -4981.796% |
| InVitro International | 635.98 Thousand USD | -519.826% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 39.936% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -260.763% |
| NovelStem International Corp. | 12 Thousand USD | -32750.0% |
| Optigenex Inc. | -102.96 Thousand USD | 3928.448% |
| PharmChem, Inc. | 3.9 Million USD | -0.964% |
| Proteome Sciences plc | 2.09 Million USD | -88.016% |
| Rennova Health, Inc. | 6.26 Million USD | 37.112% |
| RushNet, Inc. | 1.1 Million USD | -256.866% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -360.205% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1076.354% |
| Todos Medical Ltd. | 4.31 Million USD | 8.538% |